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Background: In vitro-produced retinal pigmented epithelial (RPE) cells represent a novel source for retinal degenerative
disease healing.
Results: mRNA transfection outperformed plasmid transfection in cellular uptake. Modified-mRNA displayed negligible
immune activation and functional protein expression.
Conclusion:Modified mRNA transfection can be used efficiently for the engineering of RPE cells.
Significance: The modified mRNA transfection technique offers new venues for the treatment of RPE-related diseases.
Gene- and cell-based therapies are promising strategies for
the treatment of degenerative retinal diseases such as age-re-
latedmacular degeneration, Stargardt disease, and retinitis pig-
mentosa. Cellular engineering before transplantationmay allow
the delivery of cellular factors that can promote functional
improvements, such as increased engraftment or survival of
transplanted cells. A current challenge in traditional DNA-
based vector transfection is to find a delivery system that is both
safe and efficient, but usingmRNA as an alternative to DNA can
circumvent these major roadblocks. In this study, we show that
both unmodified and modified mRNA can be delivered to reti-
nal pigmented epithelial (RPE) cells with a high efficiency com-
pared with conventional plasmid delivery systems. On the other
hand, administration of unmodified mRNA induced a strong
innate immune response that was almost absent when usingmod-
ified mRNA. Importantly, transfection of mRNA encoding a key
regulator of RPE gene expression, microphthalmia-associated
transcription factor (MITF), confirmed the functionality of the
delivered mRNA. Immunostaining showed that transfection with
either typeofmRNAled to theexpressionof roughlyequal levelsof
MITF, primarily localized in the nucleus. Despite these findings,
quantitative RT-PCR analyses showed that the activation of the
expression ofMITF target geneswas higher following transfection
with modified mRNA compared with unmodified mRNA. Our
findings, therefore, show thatmodifiedmRNA transfection can be
applied to human embryonic stem cell-derived RPE cells and that
themethod is safe, efficient, and functional.
The retinal pigmented epithelium (RPE)4 is a layer of pig-
mented cells located between the choroid and the photorecep-
tors, where it serves as a part of the barrier between the blood-
stream and the retina. This monolayer of cells operates in
multiple ways, all of which are crucial for visual function,
including light absorption, recycling of retinoids, epithelial
transport, secretion of proteins, spatial ion buffering, phagocy-
tosis of the outer segments of the photoreceptors, and immune
regulation (1).
Dysfunction, degeneration, and loss of RPE cells are major
characteristics of many retinal diseases, such as Stargardt dis-
ease, Best disease, subtypes of retinitis pigmentosa, prolifera-
tive vitreoretinopathy, and age-related macular degeneration,
which all lead to gradual loss of visual acuity and, eventually, in
many cases, to blindness (2). A variety of therapeutic ap-
proaches to delay or repair retinal degeneration is under devel-
opment, including cell-based and gene replacement therapies
(2, 3). Clinical trials involving the transplantation of intact
sheets or single-cell suspensions of primary RPE cells have been
carried out with mixed results (4).
Human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs), as well as some somatic cell
types such as mesenchymal stem cells, are all attractive cell
sources for transplantation. Several reports have demonstrated
that both hESCs and hiPSCs can differentiate in vitro into a
functional monolayer of pigmented RPE-like cells (5–8) and
that human embryonic stemcell-derivedRPE can restore vision
in the retinal dystrophy rat model (9). In addition, by using a
mixture of transcription factors, fibroblasts can be directed to
trans-differentiate toward RPE-like cells (10). Recently, the first
description of transplanted human ES cell-derived RPE cells
into human patients was reported (11), and, in Japan, a pilot
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clinical study on transplantation of autologous hiPSC-RPE cells
has been initiated. Despite the great potential of these cells for
future treatment of retinal degeneration, there are still some
challenges regarding the degree of cell survival, immune rejec-
tion, and efficiency of engraftment. In addition, functional and
molecular studies have shown that human ES cell- and hiPSC-
derived RPE cells possess specific properties that are absent
from currently available cell lines, such as ARPE-19, which
make them useful for in vitro disease modeling or drug screen-
ing (6, 12, 13). Regardless of the application of hESC RPE or
hiPSC RPE, a safe, flexible, and efficient gene delivery system is
still needed. However, optimal gene delivery systems for RPE
cells are limited.
The use of synthetic mRNA as a gene delivery technique
holds several benefits over classical DNA-basedmethods. Nev-
ertheless, because of the relatively low half-life and the strong
immunogenicity of conventional mRNA, the clinical applica-
tion of this technique has been delayed. However, recent
groundbreaking advances have established that replacing uri-
dine and cytidine with pseudouridine and 5-methylcytidine,
respectively, allows synthetic mRNA to bypass the cellular
innate immune response (14), which, in turn, opens the door to
DNA-free cellular engineering strategies that would avoid any
risks of genomic recombination or insertional mutagenesis.
Because the transfectedmRNAonly has to reach the cytoplasm
to achieve protein expression, the efficiency of transfection is
also relatively high for cells that are considered to be difficult to
transfect, such as postmitotic cells, by classical DNA-based
delivery methods (because DNA must cross the nuclear enve-
lope in addition to the plasmamembrane).ModifiedmRNAhas
also been reported to have a higher translational capacity and
stability than unmodified mRNA (15, 16). Since its discovery,
transfection of modified mRNA has been applied successfully
in different research areas, including disease treatment (17–
19), vaccination (20), and regenerative medicine (21–23).
Here we demonstrate that synthetic unmodified mRNA, as
well as modified mRNA, can be delivered efficiently into RPE
cells independently of differentiation stage or confluence.
However, administration of unmodified mRNA induces nu-
clear translocation of the immunogenic transcription factors
IRF3 and p65/RelA and, consequently, a strong activation of
their target genes, IFN and TNF. In contrast, in modified
mRNA-transfected cells, nuclear localization of IRF3 or p65/
RelA is absent, showing minimal activation of TNF and IFN.
Similarly, the transcriptional activator MITF is more biologi-
cally active when expressed from modified mRNA than
unmodified mRNA, as evidenced by the higher activation of its
target genes. Therefore, synthetic modified mRNA offers an
unprecedented opportunity for the study of RPE-related dis-
eases and, potentially, to improve the therapeutic outcomes
of degenerated RPE, including cell-based and gene-based
therapies.
EXPERIMENTAL PROCEDURES
Cell Culture andDifferentiation—HEK293T cells weremain-
tained in DMEM supplemented with 10% (v/v) FBS (Invitro-
gen) and penicillin/streptomycin at 37 °C with 5% (v/v) CO2.
The human embryonic stem cell line ES[4] (24) was cultured on
Matrigel-coated (BD Biosciences) 6-well plates andmaintained
in mTeSR1 (Stem Cell Technologies, Grenoble, France) or in
irradiated mouse embryonic fibroblast-conditioned hESC
medium containing knockout DMEM (Invitrogen), 20%
(v/v) knockout serum replacement (Invitrogen), non-essential
amino acids (Invitrogen), 2 mM L-glutamine (Invitrogen), and
50mM-mercaptoethanol (Invitrogen) and supplementedwith
basic fibroblast growth factor (10 ng/ml). The medium was
changed daily until cells were ready for passage. To initiate dif-
ferentiation, after the human ES cells had grown to confluence,
the human ES cell maintenance medium was replaced with
human ES cell medium without basic FGF and supplemented
with 10 mM nicotinamide (Sigma-Aldrich, Madrid, Spain)
(herein referred to as HES-NIC medium). The medium was
changed every third day. Pigmented clusters comprising RPE
emerged, and these colonies were allowed to grow large enough
to manually separate them from the culture. The dissected col-
onies were pooled and trypsinized (with 0.25% (w/v) trypsin) to
obtain a single-cell suspension. Enriched putative hESC-RPE
cells were then seeded onMatrigel-coatedwells and cultured in
RPE differentiation medium for a further 6–8 weeks. The cells
could be maintained in the HES-NIC differentiation medium
for up to 6monthswithout losing theirmorphology. FormRNA
transfection and subculture experiments, we used EGM2
medium (Lonza, Barcelona, Spain).
mRNA Synthesis—cDNA encoding enhanced green fluores-
cent protein (herein referred to as GFP) was amplified by PCR
and subcloned into pT7TS (Addgene, Cambridge, MA; from
Paul Krieg, University of Texas at Austin, TX) containing the
5- and 3-untranslated region sequences of Xenopus -globin
and a dA30dC30 sequence. FLAG-MITF-M was generated by
PCR and subcloned into pT7TS. Linearized GFP-pT7TS and
FLAG-MITF-M-pT7TS plasmids were used as templates for
the in vitro transcription reaction with the MEGAScript kit
(Ambion, by Invitrogen) with T7 RNA polymerase, with a 4:1
anti-reverse cap analog:GTP ratio to give an optimal percent-
age of capped transcripts. For synthesis of modifiedmRNA, the
in vitro transcription reaction substituted UTP and CTP for
pseudoUTP (UTP) and 5-methyl-CTP. The anti-reverse cap
analog) andmodifiedNTPswere ordered fromTrilink Biotech-
nologies. The unmodified and modified mRNAs were treated
with 1 l of DNase I (Ambion), heat-inactivated, and purified
by MegaClear according to the instructions of the supplier
(Ambion). Polyadenylation of the purified transcripts was per-
formed by using recombinant yeast poly(A) polymerase (USB,
Affymetrix) repurified by theMegaScript protocol. The quality
and quantity of the poly(A) tailed mRNAs was subsequently
analyzed by NanoDrop spectrophotometry and agarose gel
electrophoresis.
mRNAandDNAPlasmidTransfection—AllmRNA transfec-
tions were carried out using the Stemfect transfection reagent
in accordance with the instructions of the company (Stemgent,
Cambridge,MA). In summary, 4l of Stemfect reagent and 120
l of Stemfect buffer were used per well of a 6-well plate. For
HEK293T cells and subconfluent hESC-RPE cells, 1 g of
mRNA/well of a 6-well plate was added. For confluent and
densely packed polygonal hESC-RPE cells, 2 g of mRNA (and
8 l of Stemfect) were used. For transfection of the pmaxGFP
mRNA Transfection of Retinal Pigmented Epithelial Cells
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plasmid in HEK293 and hESC-RPE cells, FuGENE6 transfec-
tion reagent (Promega, Madrid, Spain) was used according to
the instructions of the manufacturer.
Flow Cytometry Analysis—The transfection efficiencies of
the pmaxGFP plasmid, unmodified and modified mRNAs into
hESC-RPE and HEK293T cells were determined by means of
GFP-expressing cells 24 h after transfection. Green fluorescent
protein expression was measured in a fluorescence-activated
cell sorter on a Beckman Coulter Gallios flow cytometer using
the Kaluza flow cytometry analysis software. Propidium iodide
staining was used to detect the number of dead cells.
Immunofluorescence Analysis—hESC-RPE cells were grown
on plastic coverslide chambers and fixedwith 4% (w/v) parafor-
maldehyde at room temperature for 20 min. The immunode-
tection was performed with TBS/0.2% (v/v) Triton X-100 for
permeabilization. Primary antibodies were incubated at 4 °C
overnight, and secondary antibodies were incubated at 37 °C
for 2 h. The following antibodies were used: RPE65 (Novus
Biologicals, Cambridge, UK, 1:200), OTX2 (catalog no. P15,
Santa Cruz Biotechnology, Heidelberg, Germany, 1:50), ZO-1
(catalog no. ab2272, Millipore, Darmstadt, Germany, 1:100),
BEST1 (catalog no. E6-6, Santa Cruz Biotechnology, 1:50),
MITF (catalog no. C5, Santa Cruz Biotechnology, 1:50),
M2-FLAG (Sigma-Aldrich, 1:200), NF-B/P65 (Santa Cruz
Biotechnology, 1:50), IRF3 (catalog no. FL-425, Santa Cruz Bio-
technology, 1:50), and enhanced GFP (Invitrogen, 1:200).
Images were taken on a Leica SP5 AOBS (acousto-optical beam
splitter) confocal microscope.
Transmission ElectronMicroscopy—Samples were fixed with
2.5% (w/v) glutaraldehyde for 2 h at 4 °C, post-fixed in 1%
osmium tetroxide (2 h at 4 °C), dehydrated with ethanol, and
embedded in epoxy resin. Samples were examined with a JEOL
1011 transmission electron microscope (Tokyo, Japan).
Western Blot Analysis—Whole-cell extracts were prepared
by using lysis buffer comprising 50 mM Tris-HCl (pH 7.4), 150
mMNaCl, 1% (v/v) Triton X-100, and complete protease inhib-
itormixture (Roche). Laemmli sample loading bufferwas added
to the lysed samples, which were incubated at 95 °C for 5–10
min and centrifuged for 10 min at 18, 000  g. Proteins were
separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis and transferred onto Immobilon polyvinilidene
difluoride (Millipore). For immunochemical detection, mem-
brane blots were incubated overnight at 4 °Cwith primary anti-
bodies againstOCT4 (catalog no. SC-8628, SantaCruzBiotech-
nology), TTR (catalog no. A0002, Dako, Barcelona, Spain),
RPE65 (Novus Biologicals),-Actin (catalog no. A2066, Sigma-
Aldrich), OTX2 (catalog no. P15, Santa Cruz Biotechnology),
Bestrophin (catalog no. E6-6, SantaCruzBiotechnology),MITF
(catalog no. C5, Santa Cruz Biotechnology), and M2-FLAG
(Sigma-Aldrich).
Quantitative Real-time PCR (qRT-PCR)—Cellular RNAs
were isolated by using the RNeasy mini kit according to the
instructions of the manufacturer (Qiagen, Hilden, Germany).
The concentration of total isolated RNA was measured by
NanoDrop and treated with TURBO DNase (Ambion) to
remove any residual genomic DNA. cDNA synthesis from 1 g
of total RNA was carried out using the cloned AMV (avian
myeloblastosis virus) first-strand cDNA synthesis kit (Invitro-
gen). To quantify the relative mRNA levels of typical RPE gene
markers, quantitative PCR was done with Platinum SYBR
Green quantitative PCR super mix (Invitrogen) and 25 ng of
cDNA/well. Gene expression was normalized to that of
Gapdh. Sequences of the quantitative PCR primers were
as follows: Gapdh, gtcagtggtggacctgacct (forward) and
aggggagattcagtgtggtg (reverse); Oct4, gttcttcattcactaaggaagg
(forward) and caagagcatcattgaacttcac (reverse); Best1,
tgagaccaactggattgtcg (forward) and tgaaggtggagcccataaag
(reverse); Mct3, gcctgcgttgtgctaaag (forward) and cctcgcctc-
tatttctgg (reverse); Trpm1, ccctgctgaaaggaacaaac (forward)
and tctggcttcgtgctatgtc (reverse); Trpm3, atacccagcaccaaa-
gacc (forward) and tctgaagcacggagatactg (reverse); Tyr,
acttactcagcccagcatc (forward) and tggtttccaggattacgcc (re-
verse); Rpe65, acttctcctttcaacctcttc (forward) and ctc-
aaatcctttccagcagc (reverse); Cralbp, gtggaagagaagaacttgaacc
(forward) and atggaagacacagagtccttg (reverse); Pedf, agatct-
cagctgcaagattgccca (forward) and atgaatgaactcggaggtgaggct
(reverse); Ttr, gatgggatttcatgtaaccaagag (forward) and ctgc-
ctggacttctaacatagc (reverse); Silv, gttgatggctgtggtccttg (for-
ward) and cagtgactgctgctatgtgg (reverse); TNF, cccag-
gcagtcagatcatctt (forward) and tctcagctccacgccatt (reverse);
IFN, cattacctgaaggccaagga (forward) and cagcatctgctggtt-
gaaga (reverse); TLR3, tcccaagccttcaacgactg (forward) and
tggtgaaggagagctatccaca (reverse); Mertk, ttgcagcattcaggt-
caaggaagc (forward) and ggcttgcagctgcttgatttggta (reverse);
Otx2, gaccacttcgggtatggact (forward) and tggacaaggggatct-
gacagt (reverse); Mitf, gtgccaacttctttcatca (forward) and
acctaaaccgtccattca (reverse); Pax6, tctaatcgaagggccaaatg
(forward) and tgtgagggctgtgtctgttc (reverse); and Lrat,
gaatgaggcatggacctgtt (forward) and tcctgcccaaaatctgtttc
(reverse).
RESULTS
Generation and Characterization of hESC-RPE Cells—To
obtain RPE cells from the human embryonic stem cell line ES4
(hESC[4]), we used a directed differentiation protocol,
described by Idelson et al. (5), with minor modifications.
Briefly, human ES cells were grown on Matrigel-coated 6-well
plates in mTeSRTM1- or conditioned human ES cell medium
(we defined conditioned medium under “Experimental Proce-
dures”) supplemented with 10 ng/ml basic FGF. Upon reaching
confluence, the human ES cell medium was replaced with dif-
ferentiation medium. Four weeks later, pigmented colonies
with typical RPE polygonal cell morphology were formed. After
an additional 4 weeks (approximately), we manually removed
the pigmented colonies from the cell cultures. The excised
colonies were trypsinized, and single-cell suspensions were
reseeded onto Matrigel-coated plates. Passaged hESC-RPE
cells lost their epithelial morphology and pigmentation during
the proliferation phase until they reached confluence, at which
time the typical RPE morphology was restored, consistent with
prior observations of primaryRPE, iPSC-, andESC-RPE cells (6,
7) (Fig. 1A). Transmission electron microscopy revealed the
typical structural features of RPE cells, including apical
microvilli, tight junctions, and melanosome granules (Fig. 1B).
Moreover, as shown in Fig. 1C, the pigmented cells expressed
RPE-related transcripts of genes associated with the retinal
mRNA Transfection of Retinal Pigmented Epithelial Cells
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cycle (RPE-specific protein 65 (Rpe65), cellular retinaldehyde-
binding protein (CralBP), and lecithin-retinol transferase
(Lrat)), genes involved inmelanogenesis (Silver (Silv) andTyro-
sinase (Tyr)), transcripts of RPE-related transcription factors
(microphthalmia-associated transcription factor (Mitf), ortho-
denticle homeobox 2 (Otx2), and paired box 6 (Pax6)), genes
involved in phagocytosis (c-mer proto-oncogene tyrosine
kinase (Mertk)) andmembrane transport (Trpm1, Bestrophin 1
(Best1), and monocarboxylate transporter 3 (MCT3)), and
secreted proteins (Transthyretin (TTR) and pigmented epithe-
lium-derived factor (Pedf)). In addition, protein expression of
MITF, OTX2, Best1, and RPE65 in hESC-RPE cells and OCT4
in humanES cells were confirmed byWestern blot analysis (Fig.
1D), and immunofluorescence analysis of hESC-RPE cells
revealed coexpression of RPE65, ZO-1, and OTX2. In addition,
Best1 and OTX2 were coexpressed (Fig. 1, E and F). Down-
regulation of the human ES cell marker Oct4 was confirmed by
qRT-PCR (Fig. 1C), Western blotting (Fig. 1D), and immuno-
fluorescence (data not shown).
Characterization of Sub- and Postconfluent hESC-RPE Cell
Cultures—To analyze the expression of typical RPE genes in
confluent polygonal pigmented cells and subconfluent recently
passaged cells, we harvested hESC-derived RPE cells that had
been cultured for 25 days (post-confluent culture, passage 2)
and 4 days (50–70% confluence, passage 3). Differentiated cells
were then analyzed for RPE-specific gene and protein expres-
FIGURE 1. Characterization of hESC-derived RPE cells. Pigmented clusters of polygonal cells were selected and reseeded ontoMatrigel-coated plates. After
6 weeks of proliferation into high-density cultures, the cells reacquired the morphology and pigmentation of typical RPE cells (A). B, transmission electron
microscopyof hESC-derivedRPE cells showing typical RPE characteristics: apicalmicrovilli (MV),melanin granules (M), and tight junctions (TJ). Scale bar 2m
(left panel) and1m(right panel).C, qRT-PCRanalysis of humanEScells andRPE-specific geneexpression. Relativeexpression is shownaspercentageofGAPDH
expression. Data are presented as mean S.E. of three independent experiments performed in triplicate.D, Western blot analysis on cell lysates from human
ES cells and hESC-RPE cells with antibodies against OCT4, MITF, OTX2, BEST1, RPE65, and -Actin. Immunostaining shows coexpression of RPE65, OTX2, and
ZO-1 (E) and BEST1 and OTX2 (F). DAPI was used to counterstain the nuclei (blue). Scale bars 50 m (E and F).
mRNA Transfection of Retinal Pigmented Epithelial Cells
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sion by qRT-PCR and Western blot analysis, respectively. As
shown in Fig. 2A, a drastic down-regulation of the majority of
RPE-specific transcripts (Trpm1, Trpm3, Tyr, Cralbp, Rpe65,
TTR, and Best1) was observed in the subconfluent culture (4
days after passage), whereas a more moderate down-regulation
was detected for the twoRPE-specific transcription factorsMitf
andOtx2.Western blot analysis of protein expression showed a
similar down-regulation of RPE-specific transcripts (Fig. 2B).
Interestingly, the two cell populations displayed a different
migration pattern of MITF. This might be due to different iso-
form expression because theMITF locus is regulated by multi-
ple promoters (25, 26) and/or due to posttranslational modifi-
cations (i.e. phosphorylation, sumoylation, or ubiquitylation) of
MITF (25, 27–29).We also performed immunostaining of post-
confluent hESC-RPE cells cultured for 25 days and of subcon-
fluent hESC-RPE cells cultured for 5 days after reseeding. Con-
sistent with ourWestern blot analysis, the OTX2 protein could
only be detected in polygonal hESC-RPE cells, whereas MITF
could be detected in both populations, although it was differ-
entially expressed in the 5-day cell cultures. We next per-
formed a series of time course experiments (of the passage 3
culture) and analyzed the expression of RPE-specific genes at
different time points (4, 9, 14, 23, and 37 days) during the
reestablishment of the classical pigmented polygonal mor-
phology of the cells. Consistent with the results in Fig. 2A,
the transcription factors Otx2 and Mitf had a moderate
increase in expression over time (Fig. 2D), whereas other
RPE-specific transcripts, including Best1, TTR, Trpm1,
Trpm3, and Rpe65, were highly up-regulated over time until
at least day 23 (Fig. 2E). The RPE progenitor marker Pax6
FIGURE 2.Molecular characterization of subconfluent and postconfluent polygonal hESC-RPE cells. To compare the relative expression of RPE-related
genes before (passage 2 (P2), day 25) and after (passage 3, day 4) cell passage, qRT-PCR was performed (A). The graph represents the relative gene expression
of P2 cells cultured for 25 days (normalized to GAPDH). Data are presented as the mean  S.D. of three replicates. B, Western blot analysis of the same
experiment as in A shows that RPE-specific proteins are down-regulated after passage. D, day. C, immunofluorescence detection of confluent polygonal RPE
cells and subconfluent cells (5 days after passage), showing expression of OTX2 andMITF. DAPI was used to counterstain the nuclei (blue). Scale bars 25m.
D and E, relativemRNA levels determinedby qRT-PCR of RPE-specific genes at different timepoints after passage (P3). mRNA levelswere normalized toGAPDH
and plotted relative to day 4 (4d).
mRNA Transfection of Retinal Pigmented Epithelial Cells
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had approximately similar low expression throughout the
establishment of the RPE cells (Fig. 2D).
mRNA Transfection Is Highly Efficient in Subconfluent, Early
Confluent, and Postconfluent RPE Cell Cultures—After con-
firming that the obtained hESC-RPE cells displayed the desired
characteristics, we proceeded with the transfection experi-
ments. To confirm that the synthetic mRNA, DNA plasmid,
and transfection reagents were functional, transfections were
first performed on HEK293T cells, traditionally considered
easy to transfect. The cells were harvested and stained with
propidium iodide (PI) 24 h after transfection, and transfection
efficiency (GFP-positive cells) and cell death (PI-positive cells)
were analyzed by flow cytometry. DNA transfection, making
use of complexed pmaxGFP plasmid with the FuGENE6 rea-
gent, resulted inGFP expression in 95%of the initial transfected
cells, whereas both in vitro-synthesized unmodified and modi-
fied mRNA-GFP (UTP and CTP substituted with UTP and
5-methyl-CTP) delivered with Stemfect reagent resulted in
transfection efficiencies of 80% (Fig. 3A). Propidium iodide
staining revealed that cell viability was over 90% for all delivery
approaches (Fig. 3A). The mean fluorescence intensity (mfi)
was2.2- and 3-fold higher in HEK293T cells transfected with
pmaxGFP compared with unmodified (unmod) GFP mRNA
and modified (mod) GFP mRNA, respectively (Fig. 3B).
It has been reported previously that plasmid DNA transfec-
tion in primary cultures of RPE cells, and in RPE cell line deriv-
atives such as ARPE19, is inefficient. To test whether this was
also the case with hESC-RPE cells, we transfected subconfluent
hESC-RPE cells (cultured for 4 days) with pmaxGFP. Flow cyto-
metric analysis 24 h post-transfection revealed poor transfec-
tion efficiencies with an average of 17% GFP-positive cells. On
the other hand, both unmod and mod mRNAs encoding GFP
resulted in at least 80% GFP-positive cells with a cell-viability
around 90% (Fig. 3C). Themean fluorescence intensity was also
higher for cells transfectedwith either type ofmRNA (400–500
mfi) than it was for those transfectedwith the plasmid (300mfi)
(Fig. 3D).
Next we tested the plasmid- and mRNA-based transfection
approaches on early confluence hESC-RPE cell cultures (10
days in culture). The efficiency of transfection with pmaxGFP
was only around 10%, whereas both unmod and mod
mRNA-GFP-transfected cells showed a high efficiency (90%)
24 h after transfection (Fig. 4A). The cytotoxic effect was low
(less than 10%) for both transfection approaches (Fig. 4A). The
GFP expression levels from the pmaxGFP plasmid and unmod/
modmRNA-GFPwere approximately equally high ( 400mfi)
(Fig. 4B). Representative micrographs of pmaxGFP-, unmod
mRNA-GFP-, and mod mRNA-GFP-transfected cells are
FIGURE 3. Efficiency of pmax-GFP plasmid andmRNA-GFP delivery to HEK293T and subconfluent hESC-RPE cells. HEK293T cells were transfected with
FuGENE6-pmax-GFP, Stemfect-unmod-mRNA-GFP, or Stemfect-mod-mRNA-GFP and harvested 24 h post-transfection. Efficiency of transfection and cell
viability (A) andmean fluorescence intensity (B) were quantifiedby flow cytometry. 4-day subconfluent hESC-RPE cell cultureswere transfected in a similarway
as HEK293T cells. C and D, analysis of transfection efficiency and cell viability (C) and mean fluorescence intensity (D). Error bars represent mean S.D., and
experiments were performed at least two times in duplicate.
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shown in Fig. 4C. To further evaluate the transfection capacity
of the synthetic mRNA (both unmod and mod), we also per-
formed similar experiments on postconfluence hESC-RPE cell
cultures (25 days after passage, where the RPE-specific genes
are highly expressed and the cells displayed the classical RPE
morphology with densely packed polygonal cells, see Fig. 2).
Similar trends were observed, with a decreasing efficiency of
pmaxGFP plasmid and a consistently high efficiency of
mRNA-transfected cells (Fig. 5A). Themean fluorescence inten-
sity of the cultures transfected with the two types of mRNA was
approximately similar (200–300 mfi), whereas the few cells that
wereGFP-positive afterpmaxplasmid transfectionhadanaverage
of less than 100 mfi (Fig. 5B). Typical phase-contrast and fluores-
cence micrographs of postconfluent polygonal hESC-RPE cells
24 h post-transfection are shown in Fig. 5C.
Functional Expression of Transfected FLAG-MITF-encoding
mRNA in Confluent hESC-RPE Cells—To determine whether
mRNA transfection could be used to express functional RPE-
related proteins, early confluent hESC-RPE cells were trans-
fected with unmod andmodmRNA encoding theM isoform of
the transcription factor MITF. To be able to distinguish
between endogenously and exogenously expressed MITF, our
constructs were subcloned with a FLAG tag in the N-terminal
of MITF. First, we confirmed by immunostaining that trans-
fected mRNAs (unmod and mod) encoding FLAG-MITF-M
could be delivered efficiently into hESC-RPE cells and that the
encoded protein was expressed and translocated to the nucleus
(Fig. 6A).Western blot analysis confirmed approximately equal
expression levels from unmod and mod mRNA (Fig. 6B). We
next tested whether the MITF encoded by transfected unmod
and mod mRNA was functional and capable of activating spe-
cific target genes. Confluent hESC-RPE cells were transfected
with Stemfect-complexed FLAG-MITF-MmRNA (modified or
unmodified), and cellswere harvested for subsequent qRT-PCR
analysis 16 h post-transfection. Importantly, FLAG-MITF-M,
whether expressed from unmodified or modified mRNA, up-
regulated its target genes, including SILV, TYR, and TRPM1.
FIGURE 4. Comparison of the efficiency of plasmid-based and mRNA-
based transfection on early confluence hESC-RPE cell culture. hESC-RPE
cells were subcultured for 10 days to obtain the characteristics of early con-
fluent hESC-RPE cell culture. Cellswere transfectedwith FuGENE6-pmax-GFP,
Stemfect-unmod-mRNA-GFP, or Stemfect-mod-mRNA-GFP and harvested
24 h post-transfection. Efficiency of transfection and cell viability (A) and
mean fluorescence intensity (B) were monitored by flow cytometry. C, phase
contrast and fluorescence microscopy analysis of early confluent hESC-RPE
cells 24 h after pmaxGFP, unmod-mRNA-GFP, and mod-mRNA-GFP transfec-
tion (20 objective). Scale bars  75 m. Insets show magnified images.
Experiments were performed at least twice in duplicate. Data represent
mean S.E.
FIGURE 5. Comparison of the efficiency of plasmid-based and mRNA-
based transfection on late confluence hESC-RPE cell culture. hESC-RPE
cells were subcultured for 30 days to obtain the characteristics of polygonal
polarized RPE cells. Cells were transfected with FuGENE6-pmax-GFP,
Stemfect-unmod-mRNA-GFP, or Stemfect-mod-mRNA-GFP and harvested
24 h post-transfection. Efficiency of transfection and cell viability (A) and
mean fluorescence intensity (B) weremonitored by flow cytometry. C, phase-
contrast and fluorescence microscopy analysis of late confluent hESC-RPE
cells 24 h after pmaxGFP, unmod-mRNA-GFP, and mod-mRNA-GFP transfec-
tion, respectively (20). Scale bars 75 m. Insets show magnified images.
Experiments were performed at least twice in duplicate. Data represent
mean S.E.
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However, transfected FLAG-MITF-M-modified mRNA acti-
vated the transcription of MITF-regulated genes about 5-fold
more than its unmodifiedmRNAcounterpart (Fig. 6C). In addi-
tion, when analyzing other RPE genes unrelated to the MITF
transcription factor, such asTRPM3, we did not find any signif-
icant differences between cells treated with only Stemfect (our
negative control) and cells treated with FLAG-MITF-M mod
mRNA (Fig. 6C).
Unmodified mRNA, but Not Modified mRNA, Strongly
Induces the Innate Immunity of hESC-RPE Cells—It is known
that exogenous single-stranded/double-stranded RNA can
induce the innate immune response of many cells and that
mRNA delivered to various cell types can have a cytotoxic
effect. Moreover, RPE cells express TLR3 (which recognizes
exogenous RNA) and are able to secrete many immune modu-
latory factors, such as IL-8, monocyte chemotactic protein 1
(MCP1), IFN, and TNF (1, 30). On the basis of these findings
and to test whether mRNA transfection has an effect upon the
immune response of hESC-RPE cells, we transfected cells cul-
tured for 10 days with either modified or unmodified mRNA
encoding GFP and analyzed the expression of IFN,TNF, and
TLR-3. Gene expression was analyzed by qRT-PCR 16 h post-
treatment. Strong up-regulation of all analyzed genes was
observed when unmodifiedmRNAwas used but not withmod-
ified mRNA or under basal conditions (Fig. 7A). Similar results
were obtained after transfecting the cells with unmodified and
modified mRNA encoding FLAG-MITF-M protein (data not
shown). In addition, when immunostaining was performed 6 h
post-transfection with GFP mRNA, our analysis revealed a
strong nuclear localization of p65/RelA, a subunit of NF-B,
and interferon regulatory factor 3 (IRF3), but only when
unmodified mRNA was used (Fig. 7, B and C). Both IRF3 and
NF-B are activated downstream of Toll-like receptor 3
(TLR3), whereupon they translocate to the nucleus to promote
expression of IFN andTNF, respectively. Such responses are
consistent with our qRT-PCR data (Fig. 7A).
DISCUSSION
Development of a safe and efficient viral-free gene delivery
system is one of the major challenges for gene-based therapies
of the retina. Despite recent improvements in plasmid DNA
delivery, regarding efficiency and viability, the efficiency of
transfection is still considered to be low or moderate (seldom
over 50%) (31, 32). Moreover, the most successful in vitro plas-
mid DNA gene delivery studies were on RPE-derived cell lines,
which are easier to transfect than primary RPE cells (33). In this
report, we used hESC-derived RPE cells, because they are con-
sidered to be much more similar to primary RPE than RPE cell
lines (6), to investigate the utility of using synthetic mRNA as a
novel gene delivery approach for transient protein expression
in primary RPE cells. hESC-RPE cells were generated using a
protocol reported previously with minor modifications (5). To
ensure the highest purity and maturity of our generated hESC-
RPE cultures, we selected and expanded the cultures for two
rounds of passage before characterizing the RPE cell cultures
(34). Morphological and molecular analysis of the cells showed
FIGURE 6.Nuclear localization and functional expression of FLAG-MITFmRNA transfected into hESC-RPE cells. A, immunofluorescence staining of
confluent hESC-RPE cells transfected for 16 h with unmod and mod mRNA encoding FLAG-MITF-M. DAPI (blue) was used to stain the nucleus. Scale
bars 100 m. B, Western blots of early confluent cells 16 h post-transfection. C, qRT-PCR analysis of a subset of RPE-specific genes, including reported
MITF-target genes (TYR, SILV, and TRPM1). Data are from one representative experiment of three independent experiments. Error bars represent mean
S.D.
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typical RPE features such as tight junctions, melanin granules,
apical microvilli, and expression of RPE gene transcripts and
proteins important for many of the typical RPE functions. In
many retinal diseases, including age-related macular degener-
ation and proliferative vitroretinopathy, RPE cells lose their
epithelial phenotype and cell-to-cell contact and become pro-
liferative, motile fibroblast-like cells (35). A similar process also
occurs when subculturing the RPE cells in vitro (6, 7, 36). How-
ever, when confluence is reestablished, the cells regain their
classical pigmented polygonal RPE morphology. Consistent
with similar studies on primary RPE cells, RPE cell lines, as well
as iPSC- and ES cell-derived RPE cells, we found the RPE-spe-
cific genes to be drastically down-regulated in the subconfluent
cell culture (37, 38). A time course study of RPE cell reestablish-
ment showed reexpression of RPE-specific transcripts as the
cells became confluent. These observations were coincident
with the acquisition of the typical polygonal cell shape and
the re-establishment of pigmentation. The underlying
mechanisms for the loss of RPE phenotype after cell-cell dis-
sociation are not fully understood, but studies in mouse pri-
mary RPE cells and RPE cell lines suggest that loss of contact
inhibition induces activation of canonical Wnt and Smad/
ZEB (Zinc finger E-box-binding homeobox) signaling and
subsequent activation of an epithelial-to-mesenchymal tran-
sition and unlocking of the mitotic block (37, 39, 40). More-
over, it has been shown that ZEB can bind to the MITF pro-
moter and, thereby, repress its transcription, which, in turn,
would lead to down-regulation of MITF target genes, includ-
ing many RPE-specific genes (37, 40).
Our analysis of the two transcription factors essential for RPE
maintenance and function, Otx2 and Mitf, showed a moderate
down-regulation of both transcripts in the subconfluent culture
(4 days after passage). However, when analyzing these protein
levels in 4-day subconfluent cells and 25-day cultured postcon-
fluent RPE cells, we found that theOTX2proteinwas undetect-
able, whereas the MITF protein could be detected readily
(whereas, in 25-day postconfluent cells, both MITF and OTX2
were detectable). Because many of the analyzed RPE-related
genes that were down-regulated (such as RPE65, CRALBP, and
TTR) have been reported recently to be direct targets of OTX2
(41, 42), we speculate that, together with MITF, OTX2 may be
responsible for the down-regulation of the RPE-specific genes
after cell subculture.
Despite the great interest in hESC-RPE and hiPSC RPE cells
as sources for cell therapy and in vitro disease modeling, no
studies of gene delivery of these cells have, to our knowledge,
been reported.We have shown that, as is the case for RPE cells,
hESC-RPE cells are very difficult to transfectwith plasmidDNA
complexed with commercial transfection reagent (FuGENE 6).
The highest efficiency of transfection with plasmid DNA was
achieved on subconfluent RPE cells with an efficiency of 17%,
and this decreased as the hESC-RPE cells progressed into con-
fluence. When the cells reached a polygonal morphology, less
than 1% of the cell culture was positively transfected. In con-
trast, synthetic unmodified and modified (UTP and CTP sub-
stituted with pseudo-UTP and 5-methyl-CTP) mRNAs were
delivered efficiently into subconfluent, early confluent, and
postconfluent (polygonal) RPE cells. Mean fluorescence inten-
sities were approximately equally high in cells transfected with
plasmid, unmod, and mod mRNA-GFP. This is in contrast to
some reportswheremodifiedmRNA is claimed to have a higher
translation efficiency than unmodified mRNA (15, 22), which
should result in higher fluorescence inmodmRNA-transfected
cells. The reason for this discrepancy is not clear, but because
we observed a similar results in other cells (keratinocytes,
FIGURE 7. Unmod mRNA, but not mod mRNA, induces a strong innate
immune responsevia IRF3andp65/RelAnuclear translocation.Early con-
fluent hESC-RPE cell cultures were transfected with synthetic mRNA (unmod
ormod) encoding GFP and harvested after 16 h for qRT-PCR analysis of TNF,
IFN, and TLR3 (A). Early confluent hESC-RPE cells were analyzed 6 h post-
transfection by immunofluorescence for expression and subcellular localiza-
tion of p65/RelA (B) and IRF3 (C). Anti-GFP antibody was used to detect GFP,
andDAPIwas used to stain thenucleus (B andC). Scale bars 50m.Data are
fromone representative experiment of three independent experiments. Error
bars represent mean S.D.
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HEK293T, and mesenchymal stem cells derived from adipose
tissue), we believe that it is not a cell-specific event. Further
optimization studies with different transfection agents, ratios
of modified nucleosides, and mRNA/transfection reagent
ratios are needed to understand this.
To confirm the functionality of mRNA transfection, we
chose an endogenously important RPE transcription factor:
MITF. This gene is expressed from several promoters in an
overlapping, cell-specific manner, resulting in different iso-
forms ofMITF. It has been shown that, during the development
of the murine RPE, the N-terminal 1B1b domain of MITF is
crucial (26). All MITF isoforms, except for MITF-M, contain
this domain. In addition, it has been generally assumed that the
M isoform is only expressed in melanocytes. However, recent
reports have shown relatively high levels of the M-isoform in
adult and prenatal human RPE cells as well as hESC-derived
RPE cells (43, 44).Whether different isoforms have a distinct or
overlapping function in the adult RPE is not yet known. How-
ever, several reports have identified the 1B1b domain to be
responsible for regulating cytoplasmic shuttling of MITF (45,
46). In accordance with this, our initial experiments with the
transfection of MITF-A mRNA resulted in partial cytoplasmic
localization of the MITF-A protein (data not shown). On the
other hand, transfection of MITF-M mRNA gave rise to a
strong nuclear localization of the protein, a necessary condition
for correct evaluation of the transcription-regulating activity of
MITF. Because of this, we chose theM isoform for comparison
of the transcriptional functionality of the transfected mRNAs.
Functional validation showed that both unmodified and modi-
fied mRNAs encoding MITF-M were able to activate many of
the known MITF target genes, including TYR, TRPM1, and
SILV. However, the MITF-M protein expressed frommodified
mRNA activated these genesmore strongly than that expressed
from unmodified mRNA. The reason for this is not clear, but
because the expression levels of the encoded MITF-M protein
were approximately equal, we speculate that the immune
response generated by transfection with unmodified mRNA in
some way interferes with the action of MITF, either directly or
indirectly. It is known that exogenous dsRNA, as well as single-
stranded RNA forming double-stranded secondary structures,
acts as a ligand for Toll-like receptor 3 and, as such, may induce
an innate immune response (47). TLR3 activation induces the
recruitment of adapter molecules and kinases that lead to the
translocation of the transcription factors IRF3 and NF-B into
the nucleus, where they promote the expression of TNF and
type I interferons such as IFN (47, 48). Considering that TLR3
is known to be expressed in the RPE (30), our results are con-
sistent with the current literature. The nuclear localization of
RelA/p65 (anNF- subunit) and IRF3, as well as the increased
expression of IFN and TNF in RPE cells transfected with
unmodified mRNA may be attributed to TLR3 recognition
of the transfected mRNA. Moreover, it has been reported that
mRNA incorporating pseudouridine and/or methylated
nucleosides is not efficiently recognized by TLRs (14), which
explains why our transfections with modified mRNA did not
greatly induce the innate immune response.
In conclusion, we have found that synthetic mRNA can be
delivered effectively in hESC-RPE cells and that the expressed
proteins are functional. Moreover, we have shown that syn-
thetic modified mRNA can both bypass the innate immune
response, therefore minimizing cytotoxic effects, and also gen-
erate a more biologically active protein, as shown when modi-
fiedmRNA encodingMITF was transfected in hESC-RPE cells.
Although the expression from the transfected mRNA is tran-
sient and, as such, might not be applicable at the present time
for gene-based therapy treatments directly in patients, our
study establishes a unique platform to use hESC-RPE cells and
modified mRNA transfection for basic research, disease mod-
eling, or as an approach to further develop therapeutic strate-
gies for retinal degenerative disease treatments, such as cellular
mRNA engineering, to improve successful cell transplantation.
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